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Abstract
Organotypic models may provide mechanistic insight into colorectal cancer (CRC) morphology. Three-dimensional
(3D) colorectal gland formation is regulated by phosphatase and tensin homologue deleted on chromosome 10
(PTEN) coupling of cell division cycle 42 (cdc42) to atypical protein kinase C (aPKC). This study investigated PTEN
phosphatase-dependent and phosphatase-independent morphogenic functions in 3D models and assessed transla-
tional relevance in human studies. Isogenic PTEN-expressing or PTEN-deficient 3D colorectal cultures were used. In
translational studies, apical aPKC activity readout was assessed against apical membrane (AM) orientation and gland
morphology in 3D models and human CRC. We found that catalytically active or inactive PTEN constructs con-
taining an intact C2 domain enhanced cdc42 activity, whereas mutants of the C2 domain calcium binding region 3
membrane-binding loop (M-CBR3) were ineffective. The isolated PTEN C2 domain (C2) accumulated in membrane
fractions, but C2 M-CBR3 remained in cytosol. Transfection of C2 but not C2 M-CBR3 rescued defective AM orien-
tation and 3D morphogenesis of PTEN-deficient Caco-2 cultures. The signal intensity of apical phospho-aPKC cor-
related with that of Na+/H+ exchanger regulatory factor-1 (NHERF-1) in the 3D model. Apical NHERF-1 intensity thus
provided readout of apical aPKC activity and associated with glandular morphology in the model system and human
colon. Low apical NHERF-1 intensity in CRC associated with disruption of glandular architecture, high cancer grade,
and metastatic dissemination. We conclude that the membrane-binding function of the catalytically inert PTEN C2
domain influences cdc42/aPKC-dependent AM dynamics and gland formation in a highly relevant 3D CRC morpho-
genesis model system.
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Introduction
Colorectal cancer (CRC) is the third most common malignancy
and the second most common cause of cancer death despite diag-
nostic and treatment advances [1]. All stages of CRC evolution
from benign adenoma to invasive cancer involve dynamic altera-
tions of glandular architecture, ranging from reorganization of
polarized epithelium around a central lumen to complete glandular
disruption [2]. Neoplastic deregulation of glandular morphogenesis
may allow escape of tumor cells [3] or cell clusters from glandular
structures that easily penetrate matrix barriers [4]. Histologic grad-
ing of these phenomena in human CRC has major prognostic
significance [5].
Mechanistic insight into cancer morphology has been provided by
fundamental studies in three-dimensional (3D) organotypic models
[6,7]. Development and maintenance of glandular architecture
involves coordinated assembly of a uniform apical membrane (AM)
interface around a central lumen, guided by a correctly oriented
mitotic spindle [6]. Spindle mispositioning promotes AM misassembly
at ectopic sites, and subsequent enlargement of aberrant AM loci
induces a vacuolar, multilumen phenotype [6]. Molecular regulators
of spindle orientation also modulate apical junctional complexes
implicated in cell-cell adhesion [8]. Defective spindle orientation
may thus link AM dynamics [6] and junctional adhesion instability
[9] implicated in glandular dysmorphogenesis and tumor cell escape
from glands [10] during cancer progression.
Many tumor suppressors function by regulation of spindle orienta-
tion [11] and epithelial morphogenesis [12,13]. Deficiency of the phos-
phatase and tensin homologue deleted on chromosome 10 (PTEN)
tumor suppressor associates with aberrant gland morphology in
adenomas [14] and dysmorphic high-grade CRCs [15,16]. PTEN
engages a highly conserved apical polarity pathway involving the
GTPase cell division cycle 42 (cdc42) [7,17], interacting partition-
ing defective polarity (PAR) proteins and atypical protein kinase C
(aPKC) [17,18] that regulates spindle orientation [19] and AM dy-
namics [20,21]. Disruption of cdc42/partitioning defective polarity
signaling attenuates apical enrichment of aPKCζ and promotes spin-
dle misorientation and glandular morphology defects [19]. We
have shown that incomplete knockdown of PTEN in an isogenic
Caco-2 organotypic model (Caco-2 ShPTEN cells) deregulates cdc42
and induces AM mispositioning and development of a multilumen,
vacuolar phenotype evocative of high-grade cancer [7]. PTEN has
phosphatase-dependent and phosphatase-independent functions [22],
but neither oncogenic phosphatidylinositol 3-kinase signaling [23]
nor phosphatidylinositol 3-kinase–modulating treatment [7] influ-
enced AM coordination or Caco-2 gland development [7,23]. Rele-
vant PTEN-dependent mechanisms thus remain unclear. While 3D
Caco-2 models provide compelling insights into molecular regulation
of AM orientation and glandular organization, clinical validation has
been lacking.
To address these knowledge gaps, we investigated effects of dis-
tinct PTEN functional domains by transfection of wild-type (wt)
PTEN and various catalytically active or inactive PTEN mutants.
Effects were assessed on cdc42 activation and/or AM orientation and
3D Caco-2 glandular morphogenesis. Here, we show that the catalyti-
cally inert PTEN C2 domain enhanced cdc42 activity and had
pro-morphogenic properties in a PTEN-deficient Caco-2 model.
Fundamental attributes of the model, namely, links between apical
aPKC activity readout and gland morphology, were conserved and
had prognostic significance in CRC.
Materials and Methods
Reagents and Antibodies
All laboratory chemicals were purchased from Sigma-Aldrich
(Dorset, United Kingdom) unless otherwise stated. The antibodies used
in this study were mouse anti-PTEN (Cell Signaling Technology,
Danvers, MA); mouse anti-cdc42 and mouse anti–E-cadherin (BD
Biosciences, Oxford, United Kingdom);mouse anti–Na+/H+ exchanger
regulatory factor-1 (NHERF-1; LifeSpan Biosciences, Seattle, WA);
rabbit anti-aPKCζ (ab51157), rabbit anti–phospho-aPKC (p-aPKC;
Thr560; ab62372), and rabbit anti–glyceraldehyde phosphate dehydro-
genase (GADPH; ab9485; Abcam, Cambridge, MA); rabbit anti-
hemagglutinin (HA) and anti–green fluorescent protein (GFP; New
England Biolabs, Hitchin, United Kingdom). These primary antibodies
were used where appropriate in conjunction with Alexa Fluor 568 (anti-
rabbit) and Alexa Fluor 488 (anti-mouse; Molecular Probes, Invitrogen,
Carlsbad, CA) and/or anti-mouse cyanine 5 (Jackson ImmunoResearch,
Newmarket, United Kingdom) for confocal microscopy.
Cell Lines
PTEN-wt and PTEN-deficient polarizing Caco-2 and Caco-2
ShPTEN colorectal cells [7] were used (see Cell Transfections section
below). A PTEN-null subclone of HCT116 cells (PTEN−/− HCT116
cells) [24] was also used for signaling experiments. Caco-2 clones were
cultured in minimal essential Eagle’s medium supplemented 10% fetal
calf serum, 1 mM non-essential amino acids, and 1 mM L-glutamine
at 37°C in 5%CO2. PTEN
−/−HCT116 cells were cultured inMcCoys
5Amedia supplemented with 10% fetal calf serum, 1 mM L-glutamine,
and 1 mM sodium pyruvate.
Cell Transfections
Stable PTEN-deficient Caco-2 ShPTEN cells were generated by
transfection of parental Caco-2 cells with replication-defective retro-
viral vectors encoding PTEN short hairpin RNA (shRNA), using the
Phoenix Retroviral Expression System (Orbigen, San Diego, CA) [25]
as we have previously described [7,26]. Briefly, Phoenix Eco retroviral
packaging cells (Orbigen) were transfected with pMKO.1 puro PTEN
shRNA or pMKO.1 puro empty vector (EV) retroviral expression
vectors (Addgene, Cambridge, MA), and the supernatant containing
recombinant retroviral vectors encoding PTEN shRNA or EV only
was collected after 48 hours. Viral supernatant was centrifuged at
2000 rpm and then added to Caco-2 cultures for 48 hours at 37°C
in 5% CO2. Caco-2 transfectants were then incubated in 1 μg/ml
puromycin for 7 days for selection of ShPTEN or EV-only positive
subclones [7,26].
Transient or stable transfections with wt or mutant PTEN con-
structs were carried out using GeneJuice Transfection Reagent, as
we previously described [7,26]. PTEN−/− HCT116 PTEN cells were
transiently transfected with wt PTEN or catalytically active or inac-
tive mutants. In Caco-2 ShPTEN cells, many constructs would be
repressed by the stably expressed PTEN shRNA that targets a 58-bp
region within the PTEN phosphatase coding region [25]. For this
reason, PTEN constructs containing a wt or mutant phosphatase
domain were not used in these cells. Caco-2 ShPTEN cells were
stably transfected with EV only, the isolated PTEN C2 domain (C2),
or a C2 domain construct mutated at the calcium binding region 3
membrane-binding loop (C2 M-CBR3) in pEGFP expression vectors.
In transient transfections, cells were lysed after 48 hours and cell
lysates were probed as described in Protein Extraction and Western
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Blot Analysis section. Stable Caco-2 ShPTEN subclones expressing
EV, C2, or C2 M-CBR3 were selected in 500 μg/ml G418 and then
used in further experiments.
Cell Treatment
Colorectal cells were treated with an aPKC pseudosubstrate inhib-
itor (PSI) peptide containing a membrane-targeting myristoylation
tag that functions as an effective aPKC inhibitor (aPKC-PSI) [27].
aPKC-PSI treatment may induce rapid apoptosis in various cell types
at concentrations between 16 and 50 μM [19,28,29]. In this study,
the minimal aPKC-PSI concentration that suppressed p-aPKC was
determined on initial dose-range studies. Caco-2 cells in 3D culture
were then continuously exposed to this minimum aPKC-PSI dose. Ef-
fects were assessed on AM p-aPKC, AM NHERF-1 signal intensity
and 3D morphogenesis. Caco-2 cells were also treated with sodium
butyrate (NaBt), a short-chain fatty acid that upregulates PTEN ex-
pression [26,30,31] and PTEN-dependent cdc42 activity [26]. In
separate experiments, cells were treated with 1 mM NaBt versus
vehicle only (VO) control for 48 hours for Western blots or glutathione
S-transferase (GST) pull-down assays or every 48 hours for 12 days in
morphogenesis experiments.
Cell Fractionation
Experiments were conducted as we have previously described
[7]. Briefly, cultured cells were isolated in lysis buffer containing
protease inhibitors, sonicated, and centrifuged, and the supernatant
was retained as the cytosolic fraction. The pellets were resuspended
in buffer with 1% Triton X-100 and 0.1% sodium dodecyl sulfate
and incubated for 1 hour at 4°C. Membrane fractions were obtained
by centrifugation, and the insoluble pellets were discarded [7]. In
separate experiments, protein extraction, Western blot analysis, and
pull-down assays were conducted in isolated cell membrane and
cytosolic fractions.
Protein Extraction and Western Blot Analysis
As previously described [7], proteins were resolved using gel electro-
phoresis, followed by Western blot analysis onto nitrocellulose mem-
branes. Membranes were probed using antibodies as indicated in the
text. Experiments were repeated in triplicate.
Cdc42 GST–p21-Activated Kinase Pull-Down Assays
Cdc42 activity was assayed by GST–p21-activated kinase pull-down
assay as previously described [7,26]. Briefly, cells were grown on
90-mm dishes and lysed with 50 mM Tris-HCl (pH 7.5), 1% Triton
X-100, 100 mMNaCl, 10 mMMgCl2, 5% glycerol, 1 mMNa3VO4,
and protease inhibitors (Roche Diagnostics, West Sussex, United
Kingdom). Lysates were centrifuged at 12,500g for 10 minutes. GST–
p21-activated kinase fusion protein coupled with Glutathione Sepharose
4B beads (GE Healthcare, Nottingham, United Kingdom) was added
to 1 mg of cell lysate. The beads were centrifuged after 1 hour, washed
three times, and resuspended in Laemmli buffer with 1 mM DTT.
GTP-bound cdc42 was assayed by Western blot analysis.
Three-Dimensional Morphogenesis Assays
Caco-2 and Caco-2 ShPTEN cells were cultured and embedded in
Matrigel (BD Biosciences) matrix, as previously described [7]. Briefly,
6 × 104 trypsinized cells were mixed with Hepes (20 mM) andMatrigel
in a final volume of 100 μl, which was plated onto each well of an
eight-well chamber slide (Millipore, Watford, United Kingdom),
allowed to solidify for 30 minutes at 37°C, and subsequently overlaid
with 400 μl of media per well. Cells were cultured and harvested for
imaging of 3D morphology by confocal and/or bright-field fluorescence
microscopy (FM). Confocal microscopy was conducted at sequential
intervals of 2, 4, and 12 days.
Confocal Microscopy
Embedded 3D glandular cultures were fixed in 4% paraformaldehyde
for 20 minutes and processed for immunofluorescence, as previously
described [7]. Briefly, glands were permeabilized with 0.5% Triton
X-100, rinsed, and blocked in buffer containing 0.1% BSA and 5%
goat serum. Glands were incubated overnight in primary antibodies
against E-cadherin as a basolateral membrane marker and aPKCζ as
an AM marker. p-aPKC (Thr560) immunofluorescence was used as a
marker of aPKC activity [32]. Glands were also incubated in primary
antibodies against NHERF-1. Apical NHERF-1 signal intensity was
then assessed against that of p-aPKC. The preparations were washed
with immunofluorescence buffer (three times, 20 minutes each) and
incubated with anti-mouse and/or anti-rabbit Alexa Fluor antibodies.
DNA was stained with 4′,6-diamino-2-phenylindole (DAPI) and
Figure 1. PTEN functional domains and cdc42 activation. (A) PTEN constructs. Details of wt PTEN and mutant constructs are provided in
the text. (B) Effects of PTEN constructs on cdc42 activation in PTEN−/− HCT116 cells. PTEN−/− HCT116 cells were transfected with HA-
tagged wt or mutant PTEN constructs. Data are shown in two panels, each containing wt PTEN and EV, placed side by side. Differential
gel migration according to size of deletion constructs is shown in the left HA-tagged protein blot. Those constructs containing a C2
domain with intact CBR3 loop (PTEN-wt, PTEN C124S, PTEN G129E, PTEN 1-353, PTEN 175-403) enhanced cdc42 activity more than EV
or the PTEN M-CBR3 mutant. (C) Effects of PTEN C2 domain constructs on cdc42 activation in PTEN−/− HCT116 and Caco-2 ShPTEN
cells. PTEN−/− HCT116 cells or Caco-2 ShPTEN cells were transfected with a GFP-tagged, isolated wt C2 domain or a C2 domain con-
struct mutated at the CBR3 membrane-targeting loop (C2 M-CBR3) versus EV. Detection of GFP tags using specific antibodies is shown.
The wt C2 domain (C2) enhanced cdc42 activity more than C2 M-CBR3 or EV, in PTEN−/− HCT116 cells and Caco-2 ShPTEN cells. (D)
Subcellular localization of PTEN C2 domain constructs. Expression of GFP-labeled C2, C2 M-CBR3, and EV is shown in cytosol or mem-
brane fractions of Caco-2 ShPTEN cells, identified using anti-GFP antibody. Expressions of the cytosolic marker tubulin and membrane
marker E-cadherin are shown (left panel). C2 versus C2 M-CBR3 expression in total cell lysate is shown to indicate transfection efficiency.
Differential gel migration according to size is shown for GFP-C2 and GFP-EV (right panel). (E) Subcellular localization of PTEN C2 domain
constructs. Arbitrary densitometry values in Caco-2 ShPTEN cells transfected with GFP-labeled C2 (left two columns) or C2 M-CBR3
(right two columns). Values for accumulation in cytosol and in membrane fractions for C2 versus C2 M-CBR3 were 137 ± 8.5 versus
236 ± 8.7 (cytosol) and 221 ± 4.8 versus 122 ± 7.2 (membrane) [arbitrary densitometry units; P < .001; two-way ANOVA].
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chamber slides were mounted using VECTASHIELD Mounting
Medium (Vector Scientific, Belfast, United Kingdom). Sequential
three-color scan images were taken at gland midsections at room temper-
ature using a Leica SP5 confocalmicroscope on anHCXPLAPO lambda
blue 63× 1.40 oil immersion objective at 1× or 2× zoom. Images were
collected, processed, and merged, and scale bars were added using LAS
AF Leica Confocal Imaging Software (Leica, Wetzlar, Germany). In
studies of Caco-2 ShPTEN glands transfected with PTEN C2 domain
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constructs, the fluorescent emission spectrum used for visualizing
E-cadherin (secondary antibody label of Alexa Fluor 488) overlapped
with that of GFP fluorescence. In these experiments, an anti-mouse
cyanine 5 antibody conjugate was used for imaging of E-cadherin, with
four-color confocal microscopy. The ImageJ toolkit (National Institutes
of Health, Bethesda, MD) was used to measure apical signal intensity
of p-aPKC or NHERF-1 in untreated and aPKC-PSI–treated Caco-2
glands. Total apical domains surrounding gland lumens were cap-
tured in rectangular ImageJ selection windows, and fluorescence was
quantified, plotted, and statistically analyzed.
Figure 2. Caco-2 and Caco-2 ShPTEN glandular morphogenesis. (A) Progressive Caco-2 glandular morphogenesis. Nuclei were stained
in developing glands with DAPI (blue), whereas immunolabeling with anti–E-cadherin (green) and anti-aPKC antibodies was conducted to
identify basolateral membrane (green) and AM (red), respectively. Morphology assessments were conducted at 2, 4, and 12 days of culture.
A well-formed AM indicated by anti-aPKC immunofluorescence is oriented around single central lumen. (B) Progressive Caco-2 ShPTEN
glandular morphogenesis. PTEN-deficient Caco-2 ShPTEN glands showed misorientation of the aPKC AM marker (red) and multiple
lumens/vacuoles (arrows) as early as 4 days of culture. (C) Single lumen formation during progressive Caco-2 and Caco-2 ShPTEN glandular
morphogenesis. Summary data of single lumen development in Caco-2 and Caco-2 ShPTEN glands (Caco-2 vs Caco-2 ShPTEN after 12 days
of culture, 65.5 ± 2.75% vs 38 ± 2.68%; n = 3; P < .01; ANOVA) are shown.
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Histomorphic Assays in Human CRC
Specimens from 40 non-consecutive patients who underwent sur-
gery for primary CRC at the Royal Victoria Hospital (Belfast, United
Kingdom) between 2008 and 2011were assessed. Samples were selected
on the basis of histology reports to provide approximately equal
numbers with good, intermediate, and poor differentiation by conven-
tional histologic grading criteria [33]. All histomorphic data from
hematoxylin and eosin–stained slides were reviewed, and clinical data
were obtained from corresponding reports. Clinicopathologic infor-
mation included greatest tumor dimension, Dukes and Tumor, Node,
Metastasis stage, and the number of regional lymph nodes involved
by metastasis.
Assessment of Gland Formation in Human CRC
Archival paraffin-embedded CRC specimens with surrounding nor-
mal mucosa were sectioned at 6-μm intervals and hematoxylin and
eosin stained. Each sample was evaluated by one pathologist (M.L.)
Figure 3. Effects of C2 domain transfections on Caco-2 ShPTEN gland morphogenesis. (A) Effects of C2 domain constructs on Caco-2
ShPTEN morphogenesis at 4 days. Stable transfection of Caco-2 ShPTEN cells with C2 (middle row) but not C2 M-CBR3 (bottom row) or
EV (top row) rescued single lumen formation during epithelial morphogenesis. Bright-field FM (BF; first column), FM for GFP (green; second
column), or overlay (third column) images are shown; 10× 0.30 dry objective at ×10magnification.White arrows indicate abnormal lumens.
Scale bar, 10 μM. (B) Effects of C2 domain constructs on Caco-2 ShPTEN morphogenesis at 12 days. Caco-2 ShPTEN 3D cultures after
stable transfection with GFP-tagged C2 (middle row), C2M-CBR3 (bottom row), or EV (top row). Confocal midsections of glands imaged for
DAPI (blue), E-cadherin (cyan), GFP (green), and aPKC (red) after 12 days of culture. GFP expression (third column) confirms stable trans-
fection with wt or mutant GFP-labeled C2 domain constructs or GFP-labeled EV. White arrows indicate abnormal lumens; 63× 1.40 oil
immersion objective at ×2 magnification. Scale bar, 10 μM. (C) Effects of C2 domain transfections on Caco-2 ShPTEN single lumen for-
mation at 12 days. Single lumen formation in Caco-2 ShPTEN glands after transfection (EV vs C2 vs C2 M-CBR3 = 43.5 ± 4.0% vs 73.0 ±
4.4% vs 46.0 ± 5.3%; P = .022; ANOVA; n = 3).
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for gland formation according to the method described by Ueno et al.
[5]. Briefly, a CRC region in which gland formation is totally absent
is defined as the poorly organized region (POR). Grade III is applied
to tumors for which the POR fully occupies the microscopic field of
a ×40 objective lens. For tumors with a smaller POR, clusters of greater
than or equal to five cancer cells without a gland structure were counted
in the microscopic field of a ×4 objective lens, in a region where
clusters were observed most intensively. Tumors with ≥10 clusters
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were classified as grade II and those with <10 clusters as grade I [5].
These grades have previously been shown to relate to CRC-specific
and overall survival [5].
aPKC and NHERF-1 Immunohistochemistry
Colonic tissue specimens were deparaffinized and hydrated as pre-
viously described [34], followed by antigen retrieval in a citrate buffer
at pH 6.3 and microwaved at 850 W for 20 minutes. The sections were
cooled in running water for 5 minutes, rinsed three times with Tris/HCl-
buffered saline (TBS) for 5 minutes, and blocked from nonspecific
endogenous peroxide staining by incubation in 3%H2O2 in methylated
spirits for 10 minutes. The anti-aPKCζ and anti–p-aPKCζ antibodies
(Abcam) were applied at dilutions between 1:50 and 1:200 in TBS,
whereas the NHERF-1 antibody (LifeSpan Biosciences; LS-B1873)
was applied at 1:200 in TBS. Antibodies were applied overnight at
4°C, and unbound antibody was removed by washing twice in TBS
for 5 minutes. Detection of primary antibody binding was achieved
using DAKO EnVision dual link anti-mouse and anti-rabbit detection
kit, according to manufacturer’s instructions. Sections were counter-
stained with Mayer’s hemalum to show nuclear details and then dehy-
drated, cleared, and mounted in synthetic mounting medium.
Assessment of aPKC or NHERF-1 Membrane Localization
in Normal Colon and CRC
Apical localization of aPKC, p-aPKC, and NHERF-1 was assessed
in tissue sections of normal colon and CRC. Initial studies involved
aPKC or p-aPKC immunohistochemistry. NHERF-1 AM localiza-
tion in CRC has been shown previously [35]. In this study, assessment
of NHERF-1 staining intensity was carried out in apical regions of
columnar epithelium of normal colon and at the centers of lumen-
like structures in CRCs. Tissue sections were then scored for AM
staining intensity on a graded scale from 0 to 3. Scoring was con-
ducted over 40 low power fields (×10 magnification) per tumor
by two independent assessors (R.T. and J.E.) who were unfamiliar
with tumor grading methodology and blinded to tumor grade. The
highest intensity of staining present in each field and the percent-
age of the field exhibiting this intensity of staining were estimated
within 20% increments. The final score for each field was taken as
the product of these assessments. Consensus scores were estimated
on completion.
Data Analysis
Descriptive statistics were expressed as the means ± SEM. Statistical
analysis of subcellular localization of PTEN C2 or C2 M-CBR3 con-
structs was performed by two-way analysis of variance (ANOVA).
Analysis of transfection or treatment effects on 3D glandular morpho-
genesis was performed by one- or two-way ANOVA or Student’s
t test. Pearson test was used to assess correlation between p-aPKC and
NHERF-1 signal intensities at the AM. To assess NHERF-1 AM
intensity (AMI) against categorical covariates of CRC histologic grades,
NHERF-1 data were log transformed and tested by a hierarchical
(nested) ANOVA analysis [36]. Correlations between NHERF-1 AMI
and lymph node involvement were investigated by Kendall τ test.
SPSS for Windows release 20.0 (IBM Corp, New York, NY) and
GraphPad Prism V5 for Windows (GraphPad Software, La Jolla, CA)
statistical software packages were used.
Results
Effects of Catalytically Active or Inactive PTEN Constructs
on cdc42 Activity
PTEN−/− HCT116 cells were transfected with wt PTEN or one
of a panel of mutant, deletion, or truncation constructs, including
PTEN C124S and G129E that lack lipid and protein phosphatase
or lipid phosphatase activity, respectively, PTEN 1-353 (lacking the
C-terminal tail), the phosphatase domain deletion PTEN 175-403,
PTEN M-CBR3 bearing the C2 domain CBR3 mutation at residues
263 to 269, the isolated C2 domain (residues186-353), and the iso-
lated C2 domain bearing the CBR3 mutation (C2 M-CBR3) [37],
in expression vectors (Figure 1A). Isolated phosphatase domains
Figure 4. NHERF-1 as readout of apical aPKC activity. (A) Effects of aPKC-PSI treatment on p-aPKC in colorectal cells. Limited dose-
response assay of aPKC-PSI treatment versus p-aPKC in colorectal cells. In Caco-2 cells, 1 μM aPKC-PSI suppressed p-aPKC. (B) Effects
of aPKC-PSI treatment on apical p-aPKC, NHERF-1, and Caco-2 gland morphogenesis. VO-treated Caco-2 glands predominantly formed
single central lumens with high apical aPKCζ activity (indicated by p-aPKCζ) and NHERF-1 signal intensity. Treatment with a myristoylated
aPKC peptide inhibitor suppressed apical aPKCζ activity (p-aPKCζ; T560) and apical NHERF-1 signal intensity and induced a multilumen
phenotype (multiple lumens indicated by white arrows). Scale bar, 10 μM. (C) Effects of aPKC-PSI treatment on p-aPKC and NHERF-1 apical
signal intensities. p-aPKC (red) and NHERF-1 (green) signal intensities were assessed in apical domains surrounding the whole circumference
of the central lumens of Caco-2 glands treated by VO (DMSO; top panel) or a myristoylated aPKC peptide inhibitor (aPKC-PSI; bottom panel;
n = 20 per treatment group). Signal intensities (mean ± SEM) are given as follows: VO–p-aPKC—21.2 ± 0.9; NHERF-1—12.1 ± 0.6; versus
aPKC-PSI–p-aPKC—4.6 ± 0.24; NHERF-1—5.7 ± 0.28). Apical p-aPKC and NHERF-1 signal intensities correlated after VO and aPKC-PSI
treatments (Pearson correlation = 0.86; P< .001). (D) Effects of aPKC-PSI treatment on Caco-2 gland lumen formation. Single central lumens
formed in 64 ± 2.6% Caco-2 glands treated with VO versus 27.5 ± 1.7% (VO) treated with aPKC-PSI (P< .001; one-way ANOVA). (E) Effects
of NaBt treatment on PTEN expression. Treatment of Caco-2 or Caco-2 ShPTEN cells with NaBt (1 mM) increased PTEN protein expression in
untransfected (Ut) Caco-2 cells and in Caco-2 ShPTEN cells after EV transfection (EV) or transfection with the isolated PTEN C2 domain (C2)
in expression vectors. (F) Summary effects of NaBt treatment on PTEN protein expression. NaBt treatment enhanced PTEN protein expres-
sion in Caco-2 cells versus VO (87.3 ± 4.7 vs 48.7 ± 2.9 arbitrary densitometry units) and in Caco-2 ShPTEN cells after EV (45.0 ± 5.5 vs
21.3 ± 2.0) or C2 transfections (48.7 ± 21 vs 24.3 ± 0.9; P < .001; two-way ANOVA; n = 3). (G) Effects of NaBt treatment on Caco-2
ShPTEN gland morphogenesis. NaBt treatment (bottom panel) enhanced single lumen formation in excess of VO (top panel) in Caco-2
ShPTEN glands. AMs in single and multilumen (white arrows) glands were identified by aPKC and NHERF-1 immunofluorescence. Scale
bar, 20 μM. (H) NaBt treatment effects on single lumen formation in Caco-2 ShPTEN glands. Summary effects of NaBt treatment on Caco-2
ShPTEN glandular morphogenesis (percentage of single lumen glands after 12 days of culture; Caco-2 ShPTEN VO = 42.0 ± 1.0 vs NaBt =
69.5 ± 1.5; P < .01; Student’s t test).
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(residues 1-185), isolated C-terminal regions (353-403), and PTEN
mutants that lack the C2 domain are unstable with low protein stability
[38] and were not investigated. Transfection of PTEN−/− HCT116
cells with wt PTEN, G129E, C124S, PTEN 175-403, and PTEN
1-353 enhanced cdc42 activation, in excess of EV-transfected con-
trols. Conversely, PTEN M-CBR3 transfection did not upregulate
cdc42 activity (Figure 1B). Transfection of PTEN−/− HCT116 or
Caco-2 ShPTEN cells with the isolated C2 domain enhanced cdc42
activity, whereas C2 M-CBR3 transfection had no demonstrable
effect (Figure 1C). Hence, PTEN constructs with an intact C2 domain
enhanced cdc42 activity in PTEN−/− HCT116 and Caco-2 ShPTEN
cells. Because PTEN colocalization with cdc42 at the AM is impli-
cated in cell polarization and 3D morphogenesis [17], we investigated
membrane localization of the PTEN C2 domain constructs in GFP-
containing expression vectors by transfection, cell fractionation, and
immunoblot experiments in Caco-2 ShPTEN cells. The intact PTEN
C2 domain showed greater membrane localization than C2 M-CBR3
or EV, whereas the C2 M-CBR3 construct was localized in the cytosol
(Figure 1, D and E).
Effects of PTEN on Stepwise 3D Glandular Morphogenesis
Although PTEN activates cdc42 [17] and is required for effective
3D epithelial morphogenesis [7,17], effects of PTEN on early Caco-2
morphogenesis stages were unclear. To investigate this theme, Caco-2
and Caco-2 ShPTEN cells were grown in 40% Matrigel, fixed,
and immunostained for E-cadherin (basolateral marker) and aPKC
(apical marker), whereas nuclear DNA was stained with DAPI at 2,
4, and 12 days of culture. Progressive glandular morphogenesis was
assessed by confocal microscopy. By 2 days, cells formed distinct
aggregates, whereas lumen formation was discernible in a minority
of Caco-2 and Caco-2 ShPTEN cultures by 4 days. Between 4
and 12 days, greater differences in glandular morphogenesis were
observed. As Caco-2 cells proliferated and glands enlarged, the
AM identified by the aPKC marker was localized at gland centers
as a uniform continuous interface with a single central lumen until
development of mature glands by 12 days (Figure 2A). Whereas
single lumens also developed in some Caco-2 ShPTEN glands
between 4 and 12 days, the majority showed gross mispositioning
of the aPKC AM marker and development of multiple lumens or
vacuoles. These changes were detectable as early as 4 days until
maturity of dysmorphic Caco-2 ShPTEN glands at 12 days (Figure 2,
B and C ).
Effects of the PTEN C2 Domain Constructs on
3D Glandular Morphogenesis
Because cdc42 could be activated in PTEN-deficient cells by trans-
fection of an isolated C2 domain but not by C2 M-CBR3, we
investigated effects of those constructs on 3D glandular morphogenesis.
Caco-2 ShPTEN cells were stably transfected with the intact PTEN
C2 domain, EV, or C2 M-CBR3 in EGFP expression vectors. Glands
were processed and imaged by bright-field FM or for GFP using spe-
cific antibodies and FM at 4 days and for aPKC, DAPI, E-cadherin,
and GFP using specific antibodies and confocal microscopy at 12 days
of culture. Transfection of Caco-2 ShPTEN cells with the intact PTEN
C2 domain rescued glandular morphogenesis, leading to formation of
a single central lumen. Conversely, the C2 M-CBR3 construct was
ineffective and was associated with a multilumen phenotype, compara-
ble to EV-transfected Caco-2 ShPTEN glands (Figure 3, A–C ). No
differences of AM localization of GFP-labeled C2 or C2M-CBR3 were
shown in 3D Caco-2 ShPTEN cultures. In summary, we found that
the isolated PTEN C2 domain but not C2 M-CBR3 rescues Caco-2
ShPTEN glandular morphogenesis.
Apical p-aPKC and NHERF-1 in 3D Colorectal Gland Models
p-aPKC is indicative of aPKC activity [32] and was suppressed in
Caco-2 cultures by aPKC-PSI treatment, at concentrations between
1 and 10 μM (Figure 4A). Caco-2 cells were then incubated in
DMSO VO or aPKC-PSI (1 μM) for 12 days in morphogenesis
studies. p-aPKC colocalized with NHERF-1 at apical domains of
VO-treated Caco-2 glands (Figure 4B). aPKC-PSI treatment sup-
pressed p-aPKC and NHERF-1 AM signal intensities and perturbed
morphogenesis leading to a multilumen phenotype in Caco-2 glands
(Figure 4, B and C). Apical signal intensities of p-aPKC andNHERF-1
correlated in untreated and aPKC-PSI–treated Caco-2 glands (Fig-
ure 4D), indicating that NHERF-1 may provide readout of apical
aPKC pro-morphogenic activity. To further investigate the use of
NHERF-1 as an AM marker, we conducted experiments aimed at
rescue of defective Caco-2 ShPTENmorphogenesis. NaBt can enhance
PTEN expression and PTEN-dependent cdc42 activity in Caco-2
ShPTEN cells [26]. Furthermore, up-regulation of PTEN by targeted
treatment can rescue Caco-2 ShPTEN morphogenesis [7]. In the pres-
ent study, NaBt treatment enhanced PTEN protein expression in
Caco-2 and Caco-2 ShPTEN wt cells and/or after EV or C2 trans-
fections (Figure 4, E and F ). NaBt treatment also rescued single
lumen formation in Caco-2 ShPTEN glands (Figure 4G ). NHERF-1
colocalized with aPKC and provided a suitable AM marker in these
experiments (Figure 4, G and H ). Caco-2 ShPTEN glands were
smaller after NaBt than VO treatment (Figure 4G).
Grading of Gland Morphology of Human CRC
Because NHERF-1 provided a useful AM marker and correlated
with apical p-aPKC, NHERF-1 AMI was assessed against gland
morphology and prognostic variables in 40 human CRCs. Maximum
tumor diameter in colectomy specimens ranged from 15 to 100
(mean ± SEM = 44.2 ± 3.32) mm. Five CRCs were Dukes stage A,
16 Dukes B, and 19 Dukes C. A mean of 14 lymph nodes was
retrieved with colectomy specimens (10-41), and a mean of 2.3
(0-17) lymph nodes was involved in tumor metastasis. None of the
CRCs was associated with clinically detectable distant metastases
at the time of colectomy. CRCs were recategorized in three grades
according to previously defined criteria for assessment of gland mor-
phology [5]. Twenty-four had a POR lacking gland formation that
fully occupied a field visualized through a ×40 objective lens and were
categorized as grade III. The remainder has smaller PORs, of whom
9 had ≥10 clusters of ≥5 cancer cells without gland morphology seen
through a ×4 objective lens and 7 had <10 such clusters, categorized as
grades II and I, respectively (Figure 5, A–C).
Assessment of AM NHERF-1 Expression against Gland
Morphology in Human CRCs
NHERF-1 enrichment at the epithelial apical domain was shown
in normal colon (Figure 6A). Conversely, aPKC and p-aPKC were
expressed but not apically localized in normal colon, making these
markers unsuitable for further translational studies (data not shown).
NHERF-1 apical intensity was graded 0 to 3 in normal mucosa at least
5.0 cm distant from tumors and in CRCs, across 40 fields per section,
by two independent observers. NHERF-1 apical intensity scores were
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greater in normal mucosa (1.55 ± 0.03; Figure 6A) than in CRCs of
all grades (grade I, 0.32 ± 0.02 to grade III, 0.127 ± 0.03; P < .001;
ANOVA; Figure 6, B–E ). In CRCs, NHERF-1 AMI correlated
inversely with CRC grade (Figure 6F ) and regional lymph node
metastases (Figure 6G ).
Discussion
We and others have previously shown that PTEN regulates cdc42-
dependent 3D glandular morphogenesis [7,17]. In this report, we
investigated PTEN phosphatase–dependent or PTEN phosphatase–
independent regulation of gland development and assessed translational
relevance of 3D Caco-2 organotypic model systems. Our findings re-
veal that the PTEN C2 domain has an important pro-morphogenic
function in 3D Caco-2 models. Furthermore, associations between
AM aPKC activity readout and gland morphology in Caco-2 models
[19,23] were preserved and had prognostic significance in CRCs.
As binding partners of proteins and AM phospholipids, C2 domains
may be implicated in translocation of key molecules to membrane
subregions [39]. The intact PTEN C2 domain is biologically active,
influences polarized growth, suppresses directional migration in cell
monolayers [40], and inhibits morphogenic growth of embryonic
primitive streak mesenchyme as effectively as wt PTEN [41]. Isolated
C2 domains of other lipid-metabolizing enzymes lack these biologic
properties. For example, C2 domains of synaptotagmin-like proteins
are structurally similar to PTEN C2 [37] but do not suppress direc-
tional cell migration [40]. Furthermore, the presence of intact C2
domains in synaptotagmin-like protein mutants promotes AM lo-
calization but do not influence 3D morphogenesis of Madin Darby
caninine kidney (MDCK) cells epithelial cyst–like structures [42]. In
the present study, we found that PTEN mutants containing or com-
prising an intact C2 domain enhanced cdc42 activity in excess of EV
control in transfection studies of PTEN−/− HCT116 or Caco-2
ShPTEN cells. Conversely, transfection of membrane-targeting do-
main mutants of the CBR3 loop within the C2 domain in full-length
PTEN (PTEN M-CBR3) or within the isolated C2 domain (C2
M-CBR3) [37] had no demonstrable effects on cdc42 activity. In sub-
cellular localization studies, we found that transfected C2 constructs
accumulated in cell membrane fractions, whereas the C2 M-CBR3
mutant was predominantly retained in cytosol.
A previous study showed that PTEN activation of cdc42 may be
linked to lipid phosphatase–dependent enrichment of phosphatidyl-
inositol 4,5-bisphosphate at AMs [17]. This event attracts annexin 2, a
membrane-binding protein [43] that binds cdc42 at the AM. By this
mechanism, cdc42 is recruited to AM regions in proximity to juxta-
membrane guanine nucleotide exchange factors, leading to cdc42 activa-
tion and morphogenic growth [17]. However, multiple mechanisms can
promote cdc42 membrane clustering, including cytoskeleton-mediated
targeting [44], scaffolding proteins [45], specific guanine nucleotide
exchange factors [46], and membrane phospholipid movements [47],
suggesting some context-specific redundancy of these processes. The iso-
lated PTEN C2 domain binds the universal scaffold protein β-arrestin
with greater affinity than full-length PTEN [48]. β-Arrestins act as
platforms for orchestration of cytoskeletal processes [49] and inhibit
ARHGAP21 [50], a cdc42 GTPase activating protein [51,52]. Hence,
PTEN C2 could activate cdc42 for AM assembly and glandular mor-
phogenesis by promoting juxtamembrane accumulation of β-arrestin
and suppression of ARHGAP21. Further work beyond the scope of this
manuscript is required to investigate this concept.
Whereas PTEN modulates cdc42 signaling [7,17,26] and transfec-
tion of PTEN-deficient Caco-2 ShPTEN cells with cdc42 effectively
rescues gland morphology [7], PTEN effects on early Caco-2 glandular
morphogenesis were unclear. In the present study, we found that
PTEN knockdown was associated with impairment of AM integrity
and AM mislocalization from early stages of Caco-2 glandular mor-
phogenesis, and multiple abnormal lumens or ectopic vacuoles were
detected as early as 4 days of culture. These changes recapitulate effects
of cdc42 knockdown [6] and support the role of cdc42 as an essential
PTEN-dependent effector of early morphogenesis in this colorectal
model. Dissection of PTEN/cdc42 pro-morphogenic signaling could
thus identify therapeutic targets that may help arrest colorectal tumor
progression early in its course.
Figure 5. Histologic grading of CRC. (A) Grade I CRC. Cancers are
made up entirely of irregular glands lined by polarized epithelium
oriented around distorted central lumens. (B) Grade II CRC. The pri-
mary tumor shows gland formation, but >10 clusters of ≥5 cancer
cells lacking a gland-like structure (arrows) are observed, through
a ×4 objective lens, in the stroma. A high-power view of some clus-
ters is shown in the framed inset. (C) Grade III CRC. A POR lacking
gland morphology fully occupies the field of a ×40 objective lens.
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Because cdc42 activity in PTEN-deficient cells can be enhanced by
transfection of the isolated PTEN C2 domain (C2), we investigated
the effects of C2 domain constructs on 3D glandular morphogenesis
of PTEN-deficient Caco-2 ShPTEN cultures. We found that stable
transfection of Caco-2 ShPTEN cultures with C2 domain but not
C2 M-CBR3 rescued glandular morphogenesis and restored single
lumen formation. In a previous study, the suppressive effect of the iso-
lated PTEN C2 domain on embryonic development of primitive
streak mesenchyme was dependent on the integrity of the CBR3 loop
[41]. Taken together, these studies support an important role for the
PTEN C2 domain in cdc42 activation and morphogenesis, mediated
in part through CBR3-dependent membrane binding.
In contrast to our findings of membrane localization of the isolated
C2 domain in cell monolayer fractionation experiments, we did not
observe any clear difference of AM localization between GFP-labeled
C2 or C2 M-CBR3 constructs in our 3D morphogenesis experiments.
However, AM lipid subdomains become compartmentalized to en-
hance signal transduction efficiency during epithelial morphogenesis
and differentiation [53]. Within the AM, lipid rafts (LRs) develop
as spatiotemporal signaling platforms by clustering or exclusion of
membrane proteins and signaling molecules [54]. Selective recruit-
ment or exclusion of PTEN from AM LR domains may represent
a key mechanism for spatiotemporal control of rapid or slow Akt-
dependent processes [55]. Membrane microdomain compartmentaliza-
tion of PTEN can permit rapid Akt-activation of essential ion transport
[56] while also enabling more protracted regulation of Akt-dependent
differentiation processes [56,57]. Within the AM, PTEN predomi-
nantly localizes to LRs in terminally differentiated ileal enterocytes
[56]. Conversely, in partially differentiated Caco-2 cells, PTEN is ex-
cluded from AM LRs to enable high raft Akt2 activity [56]. Signaling
molecules may be recruited to LRs through their C2 domains [58]. In
the context of the present study, the partially differentiated status of
Caco-2 cells in developing 3D glands may impede PTEN C2 domain
recruitment to AM LRs but not from whole-cell membrane fractions
isolated from cell monolayers.
Three-dimensional culture systems recapitulate cell membrane
and junctional dynamics of normal tissue [59] and are suitable for
investigation of oncogenic disruption of glandular architecture. In
3D model systems, cdc42 promotes membrane recruitment and
activation of aPKCζ that is indispensable for apical domain devel-
opment [60] and 3D morphogenesis [19,61]. To assess disease rele-
vance of the 3D Caco-2 models, we investigated apical aPKC readout
against gland morphology in 3D Caco-2 models and human CRCs.
We found aPKC and p-aPKC expression but not apical enrichment
in human tissue sections possibly due to tissue processing, fixation
artifact, or antibody specificity limitations. Apical aPKC phosphory-
lates ezrin [62,63] that enables ezrin–NHERF-1 binding [64] and
AM localization of the complex [62]. NHERF-1 is a 50-kDa adaptor
molecule that has a key role in organization of epithelial AM pro-
teins [65]. To investigate apical NHERF-1 as a potential readout of
AM aPKC activity, we conducted colocalization/expression studies in
aPKC-PSI–treated and untreated 3D gland models.
NHERF-1 and p-aPKC colocalized at AMs of VO-treated Caco-2
3D glands, and their signal intensities were correlated. Treatment
with aPKC-PSI inhibited p-aPKCζ in Caco-2 cell monolayers,
suppressed AM p-aPKCζ and NHERF-1 signal intensities in 3D
Caco-2 cultures, and disrupted morphogenesis. Our findings con-
cerning gland development accord with previous studies showing that
aPKC-PSI induced mitotic spindle misorientation in MDCK cells
[46] and impaired 3D morphogenesis in mammary acini [61], whereas
small interfering RNA knockdown of aPKCζ induced a multilumen
phenotype in 3D Caco-2 cultures [19]. To further investigate the
Figure 6. NHERF-1 apical localization in human colon. (A) NHERF-1 apical localization in normal colon. AM localization of NHERF-1 in normal
human colon (original magnification, ×40). NHERF-1 apical intensity score (mean ± SEM) = 1.55 ± 0.03. (B) NHERF-1 apical localization
in CRC (score 3). (C) NHERF-1 apical localization in CRC (score 2). (D) NHERF-1 apical localization in CRC (score 1). (E) NHERF-1 apical
localization in CRC (score 0). (F) NHERF-1 apical intensity versus cancer grade. NHERF-1 apical intensity scores are given as follows:
grade I CRCs = 0.32 ± 0.06; grade II = 0.204 ± 0.05; grade III = 0.127 ± 0.03 (P = .02; log transformation and hierarchical ANOVA; error
bars denote SEM. (G) NHERF-1 apical intensity versus lymph node metastases. Low NHERF-1 apical expression associates with high
numbers of involved nodes (error bars denote SEM; P < .01; Kendall τ test).
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use as an AM marker, we then assessed NHERF-1 against aPKC
localization in experiments aimed at rescue of dysmorphogenesis of
PTEN deficiency. We had previously shown that NaBt upregulates
PTEN and PTEN-dependent cdc42 signaling [26] but had not pre-
viously tested butyrate against glandular morphogenesis. In the pres-
ent study, we confirmed our previous findings concerning NaBt
up-regulation of PTEN [26] and showed that NaBt treatment suc-
cessfully restored single lumen formation in Caco-2 ShPTEN glands.
In these experiments, NHERF-1 AM localization mirrored that of
aPKC. NaBt-treated glands were small in size, possibly as a result of
NaBt pro-apoptotic or pro-differentiation properties in Caco-2 and
Caco-2 ShPTEN cells [26,66] or other effects mediated by butyrate
modification of epigenetic events and gene expression in colorectal
epithelium [67].
Using a semiquantitative immunohistochemistry scoring system,
we found stronger NHERF-1 AM localization in normal colon than
in CRCs, in accord with a previous report [35]. In CRCs, we also
found an inverse relationship between AM NHERF-1 expression
and histologic grading based on gland morphology. Grade I tumors
are characterized by irregular gland lumens, whereas grade III cancers
are characterized by loss of gland lumen formation within PORs of
tumors [5]. NHERF-1 AM scores were also inversely related to meta-
static lymph node invasion. These findings support translational
relevance of the model system and suggest that suppression of AM
aPKC morphogenic signaling may have a key role in evolution of
high-grade cancer.
Collectively, this study shows that the catalytically inert PTEN
C2 domain regulates cdc42 activation, AM integrity, and 3D gland
formation in a CRC model system with high translational relevance.
Functional readout of cdc42-dependent apical aPKC activity asso-
ciates with gland morphology in model systems and CRC. Hence,
molecular dissection of apical domain biogenesis in model systems
may identify biosignatures of aggressive high-grade cancer as well as
promising targets for therapeutic intervention.
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